Mice | OcPm/BPm (%) | ObPm/BPm (%) | NOc/BPm (cells/mm) | NOb/BPm (cells/mm) |
---|---|---|---|---|
Untreated hTNFtg | Â | Â | Â | Â |
   Subchondral bone erosion | 26 ± 2 | 5 ± 2 | 13.5 ± 1.1 | 2.5 ± 0.8 |
   Cortical bone channels | 22 ± 1 | 25 ± 2 | 9.5 ± 0.7 | 11.4 ± 1.0 |
   Endosteal bone surface | 1 ± 1 | 4 ± 1 | 1.2 ± 0.2 | 1.4 ± 0.3 |
OPG-treated hTNFtg | Â | Â | Â | Â |
   Subchondral bone erosion | 1 ± 1 | 0 | 0.6 ± 0.4 | 0 |
   Cortical bone channels | 1 ± 1 | 1 ± 1 | 0.4 ± 0.4 | 0.2 ± 0.2 |
   Endosteal bone surface | 0 | 0 | 0 | 0 |
Anti-TNF treated hTNFtg | Â | Â | Â | Â |
   Subchondral bone erosion | 3 ± 3 | 36 ± 5 | 4.1 ± 1.2 | 48.3 ± 11.4 |
   Cortical bone channels | 9 ± 2 | 43 ± 10 | 8.7 ± 3.3 | 26.1 ± 7,2 |
   Endosteal bone surface | 1 ± 1 | 4 ± 1 | 2.5 ± 1.2 | 10.9 ± 5.4 |